Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large & Mid Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | UTI Large & Mid Cap Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹155.51 |
| 26 Aug 2009 | ₹52.14 |
| 08 May 2011 | ₹58.06 |
| 17 Jan 2013 | ₹64.97 |
| 30 Sep 2014 | ₹84.82 |
| 11 Jun 2016 | ₹79.69 |
| 21 Feb 2018 | ₹96.67 |
| 04 Nov 2019 | ₹85.45 |
| 16 Jul 2021 | ₹120.46 |
| 28 Mar 2023 | ₹125.19 |
| 08 Dec 2024 | ₹234.10 |
| 20 Aug 2026 | ₹242.77 |
| Metric | UTI · Regular · IDCW NAV ₹91.40 Very High risk ★★★★★ | Category median Large & Mid Cap Fund · 35 funds |
|---|---|---|
| +4.47% | +3.02% | |
| +16.46% | +9.47% | |
| +15.04% | +9.57% | |
| +11.02% | +8.51% | |
| +4.45% | +8.27% | |
| +14.74% | — | |
| +5.36% | +10.05% | |
| +5.63% | +9.17% | |
| +5.18% | +6.32% | |
| Risk | ||
| 13.70% | 15.59% | |
| 0.73 | 0.10 | |
| 0.99 | 0.12 | |
| -70.57% | -42.76% | |
| Nifty Midcap 150 | — | |
| +0.90% | -5.64% | |
| 0.80 | 0.85 | |
| 81.5% | 79.3% | |
| 70.0% | 97.2% | |
| 1.95% | 2.30% | |
| ₹6,407Cr | ₹4,527Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 60% | 40% | |
| V Srivatsa · 9.3y | — | |
| 03 Apr 2006 | — | |
| 69 | — | |
| 32.6% | — | |
| 2.2% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.